CanSinotech submitted CTA of “AC Meningococcal Conjugate Vaccine” to CFDA
CanSinotech submitted Clinical Trial Application (CTA) of “AC Meningococcal Conjugate Vaccine” to China Food and Drug Administration..
2013-05-03 READ MORE
CanSinotech submitted CTA of “ACW135Y Meningococcal Conjugate Vaccine” to CFDA
Today, CanSinotech submitted Clinical Trial Application (CTA) of “ACW135Y Meningococcal Conjugate Vaccine” to China Food and Drug Administration.
2013-02-26 READ MORE
CanSino Vaccine GMP Pilot Production Base Inaugurated
CanSino GMP pilot production base was inaugurated in the Biopharm Park, West District, TEDA. The ceremony was hosted by CanSino Biotech Inc. and Tianjin Joint Academy of Biotechnology and Medicine ...
2012-05-18 READ MORE
CanSino and Aeras Partner on Pre-clinical Studies of TB Vaccine Candidates
Tianjin CanSino Biotechnology Inc. and the Aeras Global TB Global Foundation (Aeras) (CanSino) have reached a collaborative agreement in Beijing office of Bill and Melinda Gates Foundation...
2012-04-11 READ MORE
CanSino Announces Collaboration with NRC on TB Vaccine Development
CanSino Biotech Inc. today announced a collaboration with National Research Council of Canada (NRC). As indicated in the agreement signed in Tianjin ...
2007-01-17 READ MORE
Copyright © ( 2017) CanSino Biologics Inc
For the record: 津ICP备14006666号-2